Hospital Acquired Infections Market Trend and Worldwide 2022 Foresight Report

Global Hospital Acquired Infections Market Information, by Pathogen Types (Viral, Bacterial and Fungal), by Method of Treatment

PUNE, MAHARASHTRA, INDIA, May 19, 2017 / — Global Hospital Acquired Infections Market Information, by Pathogen Types (Viral, Bacterial and Fungal), by Method of Treatment (Sterilization, Chemical, Radiation), Infection Type (Urinary Tract Infections, Blood Stream Infections, Surgical Site Infections, Gastrointestinal Infections, and Respiratory Infections) – Forecast till 2022
The global hospital acquired infections market is expected to grow at a CAGR of ~7.3% during the period 2016 to 2022. Test the market data and market information presented in more than 60 market data tables and figures spread in 84 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “The Global Hospital Acquired Infections Market Research Report – Forecast to 2022”.
A hospital acquired infection (HAI)/ nosocomial infection/ health care associated infection (HAI or HCAI), is an infection that is acquired in a health care facility which is different than the one for which the patient was admitted in the hospital. It also comprises of infections whose symptoms occur after the patient is discharged and the infections transmitted by staff of the facility. WHO estimates that 8.7% of hospital patients had nosocomial infections affecting over 1.4 million people Worldwide.

Get a sample report at .

The market driving factors are nature and virulence of the microbial agent, patient susceptibility such as immunity, presence of other diseases, environmental factors such as infected materials and bacterial load in hospitals, crowding, temperature and humidity etc. Along with bacterial resistance to drugs, age of patient, high prevalence of HAI, lack of awareness, poor training and infection control practices, poor hospital infrastructure & regulation, low expenditure on healthcare, rise of chronic diseases with prolonged stay in hospitals etc also contribute to the growth of the HAI market. Market restraints are growth of microbial resistance, spurious and counterfeit products, off label use of antiseptics and drugs, rise of disposables, increasing use of quality construction material such as ceramics and glass in buildings, huge fragmentation of market, number of players, loss of patents along with great penetration of generics etc. The major market highlights include technology advancement in the form of gas plasma sterilization technology that will drive the future global HAIs market, easy market penetration, huge possibility for market development especially in the developing regions along with diminishing, specialized services such as sterilization etc.

Global Hospital Acquired Infections Market: The global hospital acquired infections market has been evaluated to be a growing market and it is expected that the market will touch high growth figures in the future, expected to grow with CAGR of 7.3% during the forecast period. The future market will be driven by advanced plasma sterilization technology which acts at the sub atomic level and greater use of disposables. Major participants of this market are: Advanced Sterilization Products, 3M Company, Becton Dickinson and company, STERIS Corporation, Getinge AB, Cantel Medical Corp., Belimed AG, and others.

Browse complete report at .

Regional Analysis: Depending on geographic region, hospital acquired infections market is segmented into four key regions; America, Europe, Asia Pacific and Middle East & Africa. Globally, America is the largest market for hospital acquired infections as there is a consistent technological advancement and greater uptake which has projected high growth of hospital acquired infections market in this region. Europe is the second largest market for hospital acquired infections. However, the prevalence of HAI is greatest in Mediterranean and South East Asian regions. Asia Pacific region is expected to be the fastest growing region in hospital acquired infections market due to increasing investments in the healthcare sector which is providing correct diagnosis and medicine, greater unmet needs, rise of surgeries and geriatric population, increasing awareness etc.

Segmentation: Global hospital acquired infections market has been segmented on the basis of pathogen types which comprises viral, bacterial and fungal. On the basis of method of treatment; the market is segmented into sterilization, chemical, radiation and on the basis of infection type; market is segmented into urinary tract infections, blood stream infections, surgical site infections, gastrointestinal infections, and respiratory infections.

Some of the key players in this market are:
• Advanced Sterilization Products
• 3M Company
• Becton Dickinson and company
• STERIS Corporation
• Getinge AB
• Cantel Medical Corp.
• Belimed AG

Request for Discount at

Table of Contents
1 Introduction

1.1 Definition

1.2 Scope of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure:

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porter’s Five Forces Model

4.1.1 Bargaining Power of Suppliers

4.1.2 Bargaining Power of Customer

4.1.3 Intensity of Competitor’s

4.1.4 Threat of New Entrants

5 Global Hospital Acquired Infections Market, by Pathogen Types

5.1 Introduction

5.1.1 Viral

5.1.2 Bacterial

5.1.3 Fungal

6 Global Hospital Acquired Infections Market, by Method of Treatment

6.1 Introduction

6.1.1 Sterilization

6.1.3 Chemical

6.1.4 Radiation

7 Global Hospital Acquired Infections Market, by Infection Type

7.1 Introduction

7.1.1 Urinary Tract Infections

7.1.3 Blood Stream Infections

7.1.4 Surgical Site Infections

7.1.5 Gastrointestinal Infections

7.1.6 Respiratory infections

8 Global Hospital Acquired Infections Market, by Regions

8.1 Introduction

8.1.1 Americas North America South America

8.1.2 Europe Germany France UK Italy Spain Rest of Europe

8.1.3 Asia Pacific Japan China India Republic of Korea Rest of Asia Pacific

8.1.4 Middle East & Africa

9 Company Landscape

9.1 Introduction

9.1.1 Mergers Acquisitions

9.1.2 Collaborations

9.1.3 Release/New Product Launches

9.1.4 Other (Expansion, Updates, Partnership)

10 Company Profile

10.1 Advanced Sterilization Products

10.1.1 Company Overview

10.1.2 Product/Business Segment Overview

10.1.3 Financials

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.2 3M Company

10.2.1 Overview

10.2.2 Product/Business Segment Overview

10.2.3 Financials

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 Becton Dickinson and company

10.3.1 Overview

10.3.2 Product/Business Segment Overview

10.3.3 Financials

10.3.4 Key Developments

10.3.5 SWOT Analysis

10.4 STERIS Corporation

10.4.1 Overview

10.4.2 Product/Business Segment Overview

10.4.3 Financials

10.4.4 Key Developments

10.4.5 SWOT Analysis

10.5 Getinge AB

10.5.1 Overview

10.5.2 Product/Business Segment

Akash Anand
Market Research Future
+1 646 845 9312
email us here

Source: EIN Presswire